Cargando…
microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
BACKGROUND: One-third of cervical cancer patients are still diagnosed at advanced stages. The five-year survival rate is decreased in about 50% of advanced stage cervical cancer patients worldwide, and the clinical outcomes are remarkably varied and difficult to predict. One of the miRNAs known to b...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501303/ https://www.ncbi.nlm.nih.gov/pubmed/31060525 http://dx.doi.org/10.1186/s12885-019-5620-6 |